These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3112482)

  • 1. M-chlorophenylpiperazine increases blood pressure and heart rate in pithed and conscious rats.
    Bagdy G; Szemeredi K; Zukowska-Grojec Z; Hill J; Murphy DL
    Life Sci; 1987 Aug; 41(6):775-82. PubMed ID: 3112482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different serotonin receptors mediate blood pressure, heart rate, plasma catecholamine and prolactin responses to m-chlorophenylpiperazine in conscious rats.
    Bagdy G; Szemeredi K; Kanyicska B; Murphy DL
    J Pharmacol Exp Ther; 1989 Jul; 250(1):72-8. PubMed ID: 2746512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
    Aulakh CS; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that m-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors.
    Mazzola-Pomietto P; Aulakh CS; Wozniak KM; Murphy DL
    Psychopharmacology (Berl); 1996 Feb; 123(4):333-9. PubMed ID: 8867872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serotonin agonist, M-chlorophenylpiperazine, markedly increases levels of plasma catecholamines in the conscious rat.
    Bagdy G; Szemeredi K; Hill JL; Murphy DL
    Neuropharmacology; 1988 Oct; 27(10):975-80. PubMed ID: 3237317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
    Bagdy G; Sved AF; Murphy DL; Szemeredi K
    Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism.
    Cohen ML; Bloomquist WL; Snoddy HD; Fuller RW
    Life Sci; 1989; 45(13):1185-9. PubMed ID: 2507847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of 5-HT2C receptors in the m-CPP-induced antinociception in mice.
    Chojnacka-Wójcik E; Kłodzińska A; Dereń-Wesołek A
    Pol J Pharmacol; 1994; 46(5):423-8. PubMed ID: 7894529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of prejunctional 5-HT receptors mediating inhibition of sympathetic vasopressor responses in the pithed rat.
    Villalón CM; Contreras J; Ramírez-San Juan E; Castillo C; Perusquía M; Terrón JA
    Br J Pharmacol; 1995 Dec; 116(8):3330-6. PubMed ID: 8719815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional subsensitivity of 5-HT2A and 5-HT2C receptors mediating hyperthermia following acute and chronic treatment with 5-HT2A/2C receptor antagonists.
    Mazzola-Pomietto P; Aulakh CS; Tolliver T; Murphy DL
    Psychopharmacology (Berl); 1997 Mar; 130(2):144-51. PubMed ID: 9106912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive effects of ketanserin and ritanserin in the spontaneously hypertensive rat.
    Persson B; Gradin K; Pettersson A; Hedner T
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S22-4. PubMed ID: 2459509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploratory hypoactivity induced by m-trifluoromethylphenylpiperazine (TFMPP) and m-chlorophenylpiperazine (m-CPP).
    Kłodzińska A; Jaros T; Chojnacka-Wójcik E; Maj J
    J Neural Transm Park Dis Dement Sect; 1989; 1(3):207-18. PubMed ID: 2775468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
    Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM
    Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
    Dreteler GH; Wouters W; Saxena PR
    Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference of ketanserin with baroreflex control of the circulation in the conscious spontaneously hypertensive rat.
    Smits J; van Dorsten F; Struyker Boudier H
    Drugs; 1988; 36 Suppl 1():55-60. PubMed ID: 3149239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin receptors in the rat nucleus tractus solitarii and cardiovascular regulation.
    Shvaloff A; Laguzzi R
    Eur J Pharmacol; 1986 Dec; 132(2-3):283-8. PubMed ID: 3102261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
    Cohen ML; Schenck KW; Kurz KD
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular and cardiac effects of DV-7028, a selective, 5-HT2-receptor antagonist in rats.
    Pawlak D; Adamkiewicz M; Malyszko J; Takada A; Mysliwiec M; Buczko W
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):266-73. PubMed ID: 9700989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of meta-chlorophenylpiperazine (mCPP), a central serotonin agonist and vascular serotonin receptor antagonist, on blood pressure in SHR.
    Cohen ML; Kurz KD; Fuller RW
    Clin Exp Hypertens A; 1987; 9(10):1549-65. PubMed ID: 3677442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fenfluramine, m-chlorophenylpiperazine, and other serotonin-related agonists and antagonists on penile erections in nonhuman primates.
    Szele FG; Murphy DL; Garrick NA
    Life Sci; 1988; 43(16):1297-303. PubMed ID: 3172981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.